Stock Scorecard



Stock Summary for Grifols SA (GRFS) - $9.87 as of 8/29/2025 3:26:58 PM EST

Total Score

17 out of 30

Safety Score

37 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for GRFS

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for GRFS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for GRFS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for GRFS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for GRFS (37 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 0
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 1
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 4
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 8
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for GRFS

All You Need to Know About Grifols ( GRFS ) Rating Upgrade to Buy 8/28/2025 4:00:00 PM
GRFS or NBIX: Which Is the Better Value Stock Right Now? 8/20/2025 3:40:00 PM
Are Investors Undervaluing Grifols ( GRFS ) Right Now? 8/20/2025 1:40:00 PM
BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December - BioCryst Pharma ( NASDAQ:BCRX ) 7/31/2025 11:00:00 AM
BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December 7/31/2025 11:00:00 AM
New Strong Sell Stocks for July 31st 7/31/2025 9:43:00 AM
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday - First Majestic Silver ( NYSE:AG ) , AES ( NYSE:AES ) 7/9/2025 3:06:00 PM
Will Strong Asceniv Sales Drive ADMA Biologics Further? 6/27/2025 12:11:00 PM
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales? 6/16/2025 5:06:00 PM
Over 100 Organizations Launch Blood Advocacy Week 2025 Urging Congress to Make the Blood Supply a National Priority 6/9/2025 2:28:00 PM

Financial Details for GRFS

Company Overview

Ticker GRFS
Company Name Grifols SA
Country USA
Description Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2025
Next Earnings Date 11/6/2025

Stock Price History

Last Day Price 9.87
Price 4 Years Ago 11.05
Last Day Price Updated 8/29/2025 3:26:58 PM EST
Last Day Volume 413,061
Average Daily Volume 1,071,509
52-Week High 10.96
52-Week Low 6.09
Last Price to 52 Week Low 62.07%

Valuation Measures

Trailing PE 19.35
Industry PE 40.47
Sector PE 60.89
5-Year Average PE 24.61
Free Cash Flow Ratio 4.57
Industry Free Cash Flow Ratio 15.46
Sector Free Cash Flow Ratio 30.76
Current Ratio Most Recent Quarter 2.64
Total Cash Per Share 2.16
Book Value Per Share Most Recent Quarter 7.60
Price to Book Ratio 1.11
Industry Price to Book Ratio 28.68
Sector Price to Book Ratio 26.74
Price to Sales Ratio Twelve Trailing Months 1.15
Industry Price to Sales Ratio Twelve Trailing Months 25.19
Sector Price to Sales Ratio Twelve Trailing Months 13.32
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 258,224,000
Market Capitalization 2,548,670,880
Institutional Ownership 57.65%

Dividends

Ex-Dividend Date 8/12/2025
Previous Dividend Amount 0.4566
Current Dividend Amount 0.1758
Total Years Dividend Increasing 1
Trailing Annual Dividend Rate 0.18
Trailing Annual Dividend Yield 1.78%
Forward Annual Dividend Rate 0.18
Forward Annual Dividend Yield 1.78%
5-Year Dividend Payments Count 3
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 2.63%
1-Year Dividend Growth Rate Percentage -61.50%
3-Year Dividend Growth Rate Percentage -6.58%
5-Year Dividend Growth Rate Percentage -22.15%
All-Time Dividend Growth Rate Percentage 2.80%
Dividend Payout Ratio 33.81%

Income Statement

Quarterly Earnings Growth YOY 750.00%
Annual Earnings Growth 164.55%
Reported EPS 12 Trailing Months 0.51
Reported EPS Past Year 0.32
Reported EPS Prior Year 0.50
Net Income Twelve Trailing Months 297,447,000
Net Income Past Year 156,920,000
Net Income Prior Year 59,315,000
Quarterly Revenue Growth YOY 4.00%
5-Year Revenue Growth 7.18%
Operating Margin Twelve Trailing Months 18.50%

Balance Sheet

Total Cash Most Recent Quarter 558,691,000
Total Cash Past Year 979,780,000
Total Cash Prior Year 529,577,000
Net Cash Position Most Recent Quarter -6,889,132,000
Net Cash Position Past Year -7,441,333,000
Long Term Debt Past Year 8,421,113,000
Long Term Debt Prior Year 8,215,297,000
Total Debt Most Recent Quarter 7,447,823,000
Equity to Debt Ratio Past Year 0.41
Equity to Debt Ratio Most Recent Quarter 0.41
Total Stockholder Equity Past Year 5,883,727,000
Total Stockholder Equity Prior Year 5,827,166,000
Total Stockholder Equity Most Recent Quarter 5,169,080,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 673,550,000
Free Cash Flow Per Share Twelve Trailing Months 2.61
Free Cash Flow Past Year 530,801,000
Free Cash Flow Prior Year -76,730,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.04
MACD Signal 0.16
20-Day Bollinger Lower Band 6.39
20-Day Bollinger Middle Band 8.84
20-Day Bollinger Upper Band 11.30
Beta 0.97
RSI 42.31
50-Day SMA 8.17
150-Day SMA 8.17
200-Day SMA 8.77

System

Modified 8/30/2025 12:59:34 AM EST